Ensure the Safety & Performance of Implantable Devices with Pharmaron

The global market for implantable medical devices (IMDs) is projected to reach $153.8 billion by 2026, driven by biomaterials, wireless technology, and personalized medicine advancements. As these devices become more sophisticated, rigorous preclinical testing is essential to ensure biocompatibility, safety, and regulatory compliance.

Pharmaron provides GLP-compliant preclinical research for implantable medical devices, helping innovators navigate regulatory pathways and bridge the gap between preclinical and clinical development. Our state-of-the-art research facilities and expert scientific team deliver high-quality data to support 510(k), PMA, and international regulatory submissions.

Key Preclinical Services for Implantable Devices

• Biocompatibility & Foreign Body Response (FBR) Testing – Assessing immune reactions to implants
• Preclinical Animal Models – Large-animal models for orthopedic, cardiovascular, and neuromodulation devices
• Device Performance & Safety Studies – Evaluating implant longevity, stability, and physiological integration
• Regulatory-Compliant Study Design – Supporting FDA, EMA, and ISO certifications
• Histopathology & Imaging – In-depth tissue response analysis for biomaterials and medical implants